Susquehanna International Group, LLP Recursion Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$5.92 - $8.6 $1.7 Million - $2.48 Million	288,000 Added 94.89%	591,500 $3.9 Million
Q2 2024 Aug 15, 2024	SELL	$7.35 - $10.05 $140,385 - $191,955	-19,100 Reduced 5.92%	303,500 $2.28 Million
Q1 2024 May 07, 2024	BUY	$9.13 - $15.52 $226,424 - $384,896	24,800 Added 8.33%	322,600 $3.22 Million
Q4 2023 Feb 14, 2024	BUY	$5.09 - $10.79 $387,858 - $822,197	76,200 Added 34.39%	297,800 $2.94 Million
Q3 2023 Nov 14, 2023	BUY	$6.59 - $15.86 $994,431 - $2.39 Million	150,900 Added 213.44%	221,600 $1.7 Million
Q2 2023 Aug 11, 2023	BUY	$4.56 - $9.94 $126,311 - $275,338	27,700 Added 64.42%	70,700 $528,000
Q1 2023 May 16, 2023	BUY	$6.42 - $9.64 $211,218 - $317,156	32,900 Added 325.74%	43,000 $286,000
Q4 2022 Feb 14, 2023	SELL	$7.16 - $12.7 $380,912 - $675,640	-53,200 Reduced 84.04%	10,100 $77,000
Q3 2022 Nov 14, 2022	BUY	$7.83 - $13.6 $286,578 - $497,760	36,600 Added 137.08%	63,300 $674,000
Q2 2022 Aug 15, 2022	BUY	$5.04 - $9.26 $50,400 - $92,600	10,000 Added 59.88%	26,700 $217,000
Q3 2021 Nov 15, 2021	BUY	$19.03 - $41.33 $317,801 - $690,211	16,700 New	16,700 $384,000

286

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.24B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.